EUCTR2005-005725-64-IT进行中（未招募）不适用
PHASE II CLINICAL AND PHARMACOKINETIC STUDY OF PEGYLATED LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN ADVANCED OVARIAN CARCINOMA - CAGEM
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 个研究点目标入组 97 人开始时间: 2006年1月31日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 97
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •1. AGE MORE THAN 18 2. PATHOLOGICALLY CONFIRMED DIAGNOSIS OF RELAPSING OVARIUM ADENOCARCINOMA 3. AT LEAST ONE CHEMOTHERAPY REGIMEN 4. ECOG PS MINOR OR EQUAL THAN 2 5. LIFE EXPECTANCY MORE THAN 12 WEEKS 6. LVEF MORE THAN 50 7. NO OTHER MALIGNANCIES 8. NORMAL BLOOD, HEPATIC AND RENAL FUNCTIONS
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. PREGNANCY AND BREAST FEEDING; 2. ANY PREVIOUS TREATMENT WITH ANTHRACYCLINES AND GEMCITABINE; 3. HYPERSENSIBILITY TO CREMOPHOR EL-BASED PRODUCTS; 4. UNCONTROLLED INFECTIOUS DISEASES; 5. ANY RADIOTHERAPY REGIMEN DURING THE LAST 4 WEEKS; 6. CNS SYMPTOMATIC METASTASES
研究者
相似试验
招募中
2 期
A Phase2 study of the safety and efficacy of pegfilgrastism for the prevention of febrile neutropenia in patients receiving TPF therapy for squamous cell carcinoma of the head and neck.JPRN-jRCTs031220695Saito Yuki18
进行中（未招募）
1 期
Clinical and pharmacokinetic phase II study of one hour infusion of kahalalide F administered every week to patients with Non Small Cell Lung Cancer Stage IIIB with pleural effusion and stage IV, after first line chemotherapyon Small Cell Lung Cancer Stage IIIB and IV after first Line ChemotherapyMedDRA version: 5.0Level: LLTClassification code 10029514EUCTR2004-001253-29-ESPharmaMar SA34
进行中（未招募）
1 期
A study of safety and effect of adding a low dose of interferon to dasatinib in patients with newly diagnosed chronic myeloid leukemia (CML)EUCTR2011-005989-38-SEorwegian University of Science and Technology22
进行中（未招募）
1 期
A study of safety and effect of adding a low dose of interferon to dasatinib in patients with newly diagnosed chronic myeloid leukemia (CML)EUCTR2011-005989-38-NOorwegian University of Science and Technology35
进行中（未招募）
1 期
A study of safety and effect of adding a low dose of interferon to dasatinib in patients with newly diagnosed chronic myeloid leukemia (CML)EUCTR2011-005989-38-DKorwegian University of Science and Technology35